Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc –IV high‐grade serous ovarian carcinoma patients
Journal of Obstetrics and Gynaecology Research, EarlyView.
Source: Journal of Obstetrics and Gynaecology Research - Category: OBGYN Authors: Jie
Zhang
,
Ning
Liu
,
Aihong
Zhang
,
Xiangxiang
Bao Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | OBGYN | Ovarian Cancer | Ovaries | Serous Carcinoma